Document rBRkwoX72a19ooe6GgqmZpprV
A #9
Recommendations
V
1. Despite the occurrence of low average- ccrc c tfnTr'a-
t-ie^vs-- e - f PC5s , PCDDs and PCDFs in human m i i k ( breast**%* :*
feeding p cofr'-aiiiRite-a-re encouraged to be promoted a-ft-a
r . v ^ < *
ejcpan-d-e-d on the basis of o.verwhelming evidence on benefits / .>l' 'l I ^ *It
of that- -nutrient to overall health and development of
the infant.
a *J
2. Programmes for identification .a-wd surveillance of
t\
potential sources of PCEs, PCDDs and PCDFs are r eccmme n de d .
Where appropriate monitoring programmes for assessment
of levels of these contaminants in the environment and
particularly in various food items are recommended.
3. Monitoring programmes on concentrations of PCBs,
PCDDs and PCDFs are recommended to be undertaken in order
if/fU
to obtain representative data for establishment of trends
of these compounds in human .blood, adipose tissue and
milk. These data could also be used for identification
of appropriate cohorts for possible epidemiological studies.
_ > 1 ^ i* b- *y*- ' r
**
4. A large-scale epidemiological programme is needed
for improvement of assessment of health hazards in infants
associated with occurrence of PCBs, PCDDs and PCDFs in
human milk at the present average levels. A feasibility
study for such a programme is strongly recommended.
5. Data on populations heavily exposed in the past
J M ' .'i.i'v
Z 'J j '
should be^ collected and ne-v-t-ewed -4-n-- 4-t-sr4 . The possibility
of carrying out further follow-up studies on these groups